Vanguard Capital Management
CNSY

Vanguard Capital Management’s Cerenome CNSY Stock Holding History

Vanguard Capital Management’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
304,745
+207,661
+214% +$1.13M ﹤0.01% 3531
2026
Q1 		$396K Buy
+97,084
New +$736K ﹤0.01% 3711

Other funds holding CNSY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Vanguard Capital Management's CNSY Position: Q2 2026 in Review

Vanguard Capital Management increased its Cerenome (CNSY) stake by 214% in Q2 2026, buying an estimated $1.13M and bringing the position to 304,745 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

Vanguard Capital Management first reported a position in CNSY in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Vanguard Capital Management held 304,745 shares of Cerenome worth $1.33M as of Q2 2026.
  • Vanguard Capital Management bought 207,661 Cerenome shares in Q2 2026, an estimated $1.13M.
  • Cerenome made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3531 holding.
  • Vanguard Capital Management first reported a position in Cerenome in Q1 2026 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.